Skip to main content
. Author manuscript; available in PMC: 2011 Nov 16.
Published in final edited form as: Cancer Cell. 2010 Nov 16;18(5):423–435. doi: 10.1016/j.ccr.2010.10.025

Figure 8. Progression-free Survival and Overall Survival of Patients with HER2-positive Metastatic Breast Cancer Treated with Trastuzumab-based Chemotherapy with or without Concurrent rHuEPO.

Figure 8

(A) Progression-free survival.

(B) Overall survival. See also Figure S6 and Tables S1 and S2.